Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study.
Abiy AgiroJamie P DwyerYemisi OluwatosinPooja DesaiPublished in: ClinicoEconomics and outcomes research : CEOR (2023)
This study demonstrated that long-term (>3 months) outpatient treatment with SZC was associated with medical cost savings compared with no SZC therapy.
Keyphrases